TrialAnnals of clinical and translational neurology2021

Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial.

Robert A Bermel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.